Genetic epidemiology of severe, early-onset chronic obstructive pulmonary disease: Risk to relatives for airflow obstruction and chronic bronchitis

American Journal of Respiratory and Critical Care Medicine

Volumn 157, Issue 6 PART I, 1998, Pages 1770-1778

  Silverman, Edwin K ^a   Chapman, Harold A ^b   Drazen, Jeffrey M ^b   Weiss, Scott T ^b   Rosner, Bernard ^b   Campbell, Edward J ^b   O'Donnell, Walter J ^b   Reilly, John J ^b   Ginns, Leo ^b   Mentzer, Steven ^b   Wain, John ^b   Speizer, Frank E ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN;

ADULT; AGE; AIRWAY OBSTRUCTION; ALPHA 1 ANTITRYPSIN DEFICIENCY; ARTICLE; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FAMILIAL DISEASE; FEMALE; FORCED EXPIRATORY VOLUME; GENETIC EPIDEMIOLOGY; GENETIC RISK; HUMAN; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; SMOKING; SPIROMETRY;

ALPHA 1-ANTITRYPSIN DEFICIENCY; BRONCHITIS; CHRONIC DISEASE; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LUNG DISEASES, OBSTRUCTIVE; MALE; MIDDLE AGED; RISK FACTORS; SMOKING; VITAL CAPACITY;

EID: 0031807729     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.157.6.9706014     Document Type: Article

References (43)

1. Feinleib, M., H. M. Rosenberg, J. G. Collins, J. E. Delozier, R. Pokras, and F. M. Chevarley. 1989. Trends in COPD morbidity and mortality in the United States. Am. Rev. Respir. Dis. 140(Suppl.):S9-S18.
2. Kochanek, K. D., and B. L. Hudson. 1995. Advance report of final mortality statistics, 1992. Monthly Vital Statist. Rep. 43:1-73.
3. U.S. Department of Health and Human Services. 1984. The health consequences of smoking: chronic obstructive lung disease. A report of the Surgeon General. U.S. Department of Health and Human Services, Office on Smoking and Health, Bethesda, MD. (DHHS Publication No. (PHS)84-50205.
4. Burrows, B., R. J. Knudson, M. G. Cline, and M. D. Lebowitz. 1977. Quantitative relationships between cigarette smoking and ventilatory function. Am. Rev. Respir. Dis. 115:195-205.
5. Silverman, E. K., and F. E. Speizer. 1996. Risk factors for the development of chronic obstructive pulmonary disease. Med. Clin. North Am. 80:501-522.
6. Larsson, C. 1978. Natural history and life expectancy in severe alpha 1-antitrypsin deficiency, Pi Z. Acta Med. Scand. 204:345-351.
7. Silverman, E. K., J. A. Pierce, M. A. Province, D. C. Rao, and E. J. Campbell. 1989. Variability of pulmonary function in alpha 1-antitrypsin deficiency: clinical correlates. Ann. Intern. Med. 111:982-991.
8. Silverman, E. K., M. A. Province, E. J. Campbell, J. A. Pierce, and D. C. Rao. 1990. Variability of pulmonary function in alpha-1-antitrypsin deficiency: residual family resemblance beyond the effect of the Pi locus. Hum. Hered. 40:340-355.
9. Lewitter, F. I., I. B. Tager, M. McGue, P. V. Tishler, and F. E. Speizer. 1984. Genetic and environmental determinants of level of pulmonary function. Am. J. Epidemiol. 120:518-529.
10. Redline, S., P. V. Tishler, B. Rosner, F. I. Lewitter, M. Vandenburgh, S. T. Weiss, and F. E. Speizer. 1989. Genotypic and phenotypic similarities in pulmonary function among family members of adult monozygotic and dizygotic twins. Am. J. Epidemiol. 129:827-836.
11. Hankins, D., C. Drage, N. Zamel, and R. Kronenberg. 1982. Pulmonary function in identical twins raised apart. Am. Rev. Respir. Dis. 125:119-121.
12. Webster, P. M., E. G. Lorimer, S. F. P. Man, C. R. Woolf, and N. Zamel. 1979. Pulmonary function in identical twins: comparison of nonsmokers and smokers. Am. Rev. Respir. Dis. 119:223-228.
13. Larson, R. K., M. L. Barman, F. Kueppers, and H. H. Fudenberg. 1970. Genetic and environmental determinants of chronic obstructive pulmonary disease. Ann. Intern. Med. 72:627-632.
14. Kueppers, F., R. D. Miller, H. Gordon, N. G. Hepper, and K. Offord. 1977. Familial prevalence of chronic obstructive pulmonary disease in a matched pair study. Am. J. Med. 63:336-342.
15. Cohen, B. H., W. C. Ball, Jr., S. Brashears, E. L. Diamond, P. Kreiss, D. A. Levy, H. A. Menkes, S. Permutt, and M. S. Tockman. 1977. Risk factors in chronic obstructive pulmonary disease (COPD). Am. J. Epidemiol. 105:223-232.
16. Lander, E. S., and N. J. Schork. 1994. Genetic dissection of complex traits. Science 265:2037-2048.
17. Risch, N. 1990. Linkage strategies for genetically complex traits: II. The power of affected relative pairs. Am. J. Hum. Genet. 46:229-241.
18. Dockery, D. W., J. H. Ware, B. G. Ferris, Jr., D. S. Glicksberg, M. E. Fay, A. I. Spiro, and F. E. Speizer. 1985. Distribution of forced expiratory volume in one second and forced vital capacity in healthy, white, adult never-smokers in six U.S. cities. Am. Rev. Respir. Dis. 131:511-520.
19. Tager, I. B., B. Rosner, P. V. Tishler, F. E. Speizer, and E. H. Kass. 1976. Household aggregation of pulmonary function and chronic bronchitis. Am. Rev. Respir. Dis. 114:485-492.
20. Ferris, B. G. 1978. Epidemiology standardization project. Am. Rev. Respir. Dis. 118(Suppl.):1-120.
21. Gardner, R. M., J. L. Hankinson, J. L. Clausen, R. O. Crapo, R. L. Johnson, Jr., and G. R. Epler. 1987. Standardization of Spirometry: 1987 update. Official statement of the American Thoracic Society. Am. Rev. Respir. Dis. 136:1285-1298.
22. Crapo, R. O., A. H. Morris, and R. M. Gardner. 1981. Reference spirometric values using techniques and equipment that meet ATS recommendations. Am. Rev. Respir. Dis. 123:659-664.
23. Hsu, K. H. K., D. E. Jenkins, B. P. Hsi, E. Bourhofer, V. Thompson, N. Tanakawa, and G. S. J. Hsieh. 1979. Ventilatory functions of normal children and young adults: Mexican-American, white, and black. I. Spirometry. J. Pediatr. 95:14-23.
24. Pierce, J. A., and B. G. Eradio. 1979. Improved identification of anti-trypsin phenotypes through isoelectric focusing with dithioerythritol. J. Lab. Clin. Med. 94:826-831.
25. Silverman, E. K., M. A. Province, D. C. Rao, J. A. Pierce, and E. J. Campbell. 1990. A family study of the variability of pulmonary function in alpha-1-antitrypsin deficiency: quantitative phenotypes. Am. Rev. Respir. Dis. 142:1015-1021.
26. Liou, T. G., and E. J. Campbell. 1996. Quantum proteolysis resulting from release of single granules by human neutrophils. J. Immunol. 157:2624-2631.
27. Boudier, C, A. Pelletier, G. Pauli, and J. G. Bieth. 1983. The functional activity of alpha-1-proteinase inhibitor in bronchoalveolar lavage fluids from healthy human smokers and non-smokers. Clin. Chim. Acta 132:309-315.
28. Powers, J. C., and B. F. Gupton. 1977. Reaction of serine proteases with aza-amino acid and aza-peptide derivatives. Methods Enzymol. 46:208-216.
29. Zeger, S. L., and K.-Y. Liang. 1986. Longitudinal data analysis for dis-crete and continuous outcomes. Biometrics 42:121-130.
30. Liang, K.-Y., and S. L. Zeger. 1993. Regression analysis for correlated data. Annu. Rev. Pub. Health 14:43-68.
31. Silverman, E. K., J. P. Miletich, J. A. Pierce, L. A. Sherman, S. K. Endicott, G. J. Broze, Jr., and E. J. Campbell. 1989. Alpha-1-antitrypsin deficiency: high prevalence in the St. Louis area determined by direct population screening. Am. Rev. Respir. Dis. 140:961-966.
32. Hall, J. M., M. K. Lee, B. Newman, J. E. Morrow, L. A. Anderson, B. Huey, and M. C. King. 1990. Linkage of early-onset familial breast cancer to chromosome 17q21. Science 250:1684-1689.
33. Stone, E. M., J. H. Fingert, W. L. M. Alward, T. D. Nguyen, J. R. Polansky, S. L. F. Sunden, D. Nishimura, A. F. Clark, A. Nystuen, B. E. Nichols, D. A. Mackey, R. Ritch, J. W. Kalenak, E. R. Craven, and V. C. Sheffield. 1997. Identification of a gene that causes primary open angle glaucoma. Science 275:668-670.
34. Stern, E. J., W. R. Webb, A. Weinacker, and N. L. Muller. 1994. Idiopathic giant bullous emphysema (vanishing lung syndrome): imaging findings in nine patients. A.J.R. 162:279-282.
35. Davis, R. M., and T. E. Novotny. 1989. Changes in risk factors: the epidemiology of cigarette smoking and its impact on chronic obstructive pulmonary disease. Am. Rev. Respir. Dis. 140:582-584.
36. O'Donnell, D. E., and K. A. Webb. 1992. Breathlessness in patients with severe chronic airflow limitation: physiologic correlations. Chest 102: 824-831.
37. Wegner, R. E., R. A. Jorres, D. K. Kirsten, and H. Magnussen. 1994. Factor analysis of exercise capacity, dyspnoea ratings and lung function in patients with severe COPD. Eur. Respir. J. 7:725-729.
38. Postma, D. S., J. Burema, F. Gimeno, J. F. May, J. M. Smit, E. J. Steenhuis, L. T. V. D. Weele, and H. J. Sluiter. 1979. Prognosis in severe chronic obstructive pulmonary disease. Am. Rev. Respir. Dis. 119:357-367.
39. Damsgaard, T., and A. Kok-Jensen. 1974. Prognosis in severe chronic obstructive pulmonary disease. Acta Med. Scand. 196:103-108.
40. Schildkraut, J. M., N. Risch, and W. D. Thompson. 1989. Evaluating genetic association among ovarian, breast, and endometrial cancer: evidence for a breast/ovarian cancer relationship. Am. J. Hum. Genet. 45: 521-529.
41. Beaty, T. H., K. Y. Liang, S. Seerey, and B. H. Cohen. 1987. Robust inference for variance components models in families ascertained through probands: II. Analysis of spirometric measures. Genet. Epidemiol. 4:211-221.
42. Higgins, M., and J. Keller. 1975. Familial occurrence of chronic respiratory disease and familial resemblance in ventilatory capacity. J. Chronic Dis. 28:239-251.
43. Schmidt, R. A., R. W. Glenny, J. D. Godwin, N. B. Hampson, M. E. Cantino, and D. D. Reichenbach. 1991. Panlobular emphysema in young intravenous ritalin abusers. Am. Rev. Respir. Dis. 143:649-656.